5+ Best-Performing Stocks off 2023 

Archer Aviation Inc. (ACHR)

Archer Aviation, a developer of electric VTOL aircraft, secured a $215 million investment in August, and its stock has surged 272.7% in 2023.

BridgeBio Pharma Inc. (BBIO)

BridgeBio Pharma, specializing in genetic disease and cancer treatment, boasts a $4.9 billion market cap, making it an enticing buyout option. In 2023, BBIO shares surged by 292.5%. 

AppLovin Corp. (APP)

AppLovin, known for aiding app developers in discovery and monetization, touts the success of its AI-driven ad engine, Axon 2.0. In 2023, AppLovin's shares surged by 310.4%.

Reata Pharmaceuticals Inc. (RETA)

Reata Pharmaceuticals, focusing on rare disease therapies, saw a boost as the FDA greenlit its Friedreich's ataxia treatment, Skyclarys, leading to a surge in its shares in March.

IonQ Inc. (IONQ)

IonQ is at the forefront of quantum computing tech. With the quantum computing market predicted to grow 31% annually, IonQ shares have surged by 398.2% year to date.

MoonLake Immunotherapeutics (MLTX)

MoonLake Immunotherapeutics focuses on sonelokimab, a promising treatment for inflammatory diseases. The stock has gained 448.2% in 2023, buoyed by high expectations on Wall Street for the drug.

Carvana Co. (CVNA)

Carvana, an online used-car sales platform, posted a Q2 revenue decline of 24%, a 35% drop in retail units sold, and a $105 million net loss. Yet, its impressive 962.2% YTD gain stands out.